HCA · HCA Healthcare, Inc.
$407.05
-4.68 (-1.14%)
At close · Aug 19
Market Cap
$90.30B
Shares
221.84M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$407.05
Open$411.08
Day$406.81–422.00
52W close$361.32–545.13
Avg vol 30d1.6M
Short int6.1M · 2.7% float · 3.5d
Short vol48%
Last earningsJul 24, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 28
Up next
Next earnings call
Oct 23, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 28, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
+3%
above
RSI (14)
53
neutral
MACD trend
Negative
52-week position
25%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+9%
trailing
6-month return
−23%
trailing
YTD return
−13%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $395 › 200d $455 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +121 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.73% of float · ▲ +4.0% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1,332 holders — mid 3-yr range
Squeeze score
50
elevated · 0–100
Fundamentals
Revenue growth
+7%
Y/Y
EPS growth
+29%
Y/Y
Free cash flow
$7.7B
Valuation
P/E 14
below peers
Buyback
$7.2B
remaining
Balance sheet
$45.5B
net debt
Quant / Vol
risk profile
Volatility
30%
annualized · 1-yr
Max drawdown
−34%
past year
ATR
3.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 24, 2026
Revenues
· 2026
$77B – $79.5B
Net Income Attributable to HCA Healthcare, Inc.
· 2026
$6.3B – $6.7B
Adjusted EBITDA
· 2026
Non-GAAP
$15.4B – $16.1B
EPS (diluted)
· 2026
$28.70 – $30.50
Medicaid Supplemental Payment Programs
· 2026
$300M – $500M
Prior guidance
period ended
· from the 8-K filed Oct 24, 2025
Capital expenditures (excluding acquisitions)
· For the Year Ending December 31, 2025
$5B
Guided vs delivered
· last 3 settled
Revenues
full year 2024
guided $67.75B – $70.25B
$70.6B
Beat +2.3%
Diluted earnings per share
full year 2024
guided $19.70 – $21.20
$22.00
Beat +7.6%
Revenues
full year 2023
guided $63.5B – $64.5B
$64.97B
Beat +1.5%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
+3%
Bullish
RSI (14)
53
Neutral
MACD trend
Negative
Bearish
52-week position
25%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $395 › 200d $455 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +121 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.73% of float · ▲ +4.0% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1,332 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $361
Now $407 · 25%
Range high $545
vs 200-day avg -11%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $7.83B | For the Six Months Ended June 30 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 19.9% | For the Six Months Ended June 30 | — |
|
|
|||
| Admissions | 579,562 | Second Quarter | — |
| ambulatory sites of care | 2,600 | As of June 30, 2026 | — |
| Average Length of Stay (days) | 4.64 | Second Quarter | — |
| Diluted earnings per share, as adjusted non-GAAP | $7.59 | Second Quarter | — |
|
|
|||
| Emergency Room Visits | 2,526,147 | Second Quarter | — |
| Equivalent Admissions | 1,044,384 | Second Quarter | — |
| Equivalent Patient Days | 4,850,633 | Second Quarter | — |
| hospitals operated | 190 | As of June 30, 2026 | — |
| Inpatient Surgery Cases | 133,041 | Second Quarter | — |
| Licensed Beds at End of Period | 50,550 | Second Quarter | — |
| Net income attributable to HCA Healthcare, Inc., as adjusted non-GAAP | $1.69B | Second Quarter | — |
| Number of Freestanding Outpatient Surgery Centers | 118 | Second Quarter | — |
| Number of Hospitals | 190 | Second Quarter | — |
| Occupancy | 74.1% | For the Six Months Ended June 30 | — |
| Outpatient Surgery Cases | 246,947 | Second Quarter | — |
| Patient Days | 2,690,923 | Second Quarter | — |
| Same Facility Emergency Room Visits | 5,001,795 | For the Six Months Ended June 30 | — |
|
|
|||
| Same Facility Equivalent Admissions | 2,050,721 | For the Six Months Ended June 30 | — |
|
|
|||
| Same facility inpatient surgeries | 2.3% | the second quarter of 2026 | — |
|
|
|||
| Same Facility Inpatient Surgery Cases | 264,815 | For the Six Months Ended June 30 | — |
| Same facility outpatient surgeries | 3.4% | the second quarter of 2026 | — |
|
|
|||
| Same Facility Outpatient Surgery Cases | 478,091 | For the Six Months Ended June 30 | — |
| Same facility revenue per equivalent admission | 6.4% | the second quarter of 2026 | — |
|
|
|||
| Weighted Average Beds in Service | 42,905 | Second Quarter | — |
| Same facility admissions | 2.5% | the second quarter of 2026 | — |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HCA
this stock
HCA Healthcare, Inc.
|
$90.30B | -12.8% | +7.1% | 14.0 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.84B | -4.5% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.76B | +35.1% | +0.9% | 10.4 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.69B | +0.1% | +5.9% | — | 0.5% |
|
EHC
Encompass Health Corp
|
$12.07B | +14.7% | +10.5% | 19.9 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HCA | -1.8% | +9.5% | -22.6% | +1.1% | -12.8% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -1.4% | +6.6% | -34.2% | -1.8% | -25.6% |
Capital returns
Latest dividend
$0.78
/ share · ex Jun 16, 2026
Declared · upcoming
$0.78
/ share · ex Sep 16, 2026
Paid (TTM)
$3.00
/ share · 4 payouts
Dividend yield (TTM, derived)
0.74%
Buyback program
· as of Jun 30, 2026
Authorized
$10.00B
Spent (derived)
$2.79B
Remaining
$7.21B
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
860730
CUSIP
40412C101
13F (30d)
1157 filings
1122 filers
Visit website
Investor relations